Skip to main content

ADVERTISEMENT

Melissa D. Cooper

LTC Bulletin Board
06/01/2015
Amgen announced that the FDA approved Corlanor (ivabradine) for the treatment of stable heart failure (HF).
Amgen announced that the FDA approved Corlanor (ivabradine) for the treatment of stable heart failure (HF).
Amgen announced that the FDA...
06/01/2015
Annals of Long-Term Care
12/16/2015
Determining the vale of a drug may require less data than you realize
Determining the vale of a drug may require less data than you realize
Determining the vale of a drug...
12/16/2015
First Report Managed Care
News Connection
04/22/2014
A recent study showed statin therapy decreased relative cardiovascular risk by 25% [Database Syst Rev. 2013;1:CD004816]. In 2013, the American College of Cardiology and the American Heart Association (ACC/AHA) made recommendations for...
A recent study showed statin therapy decreased relative cardiovascular risk by 25% [Database Syst Rev. 2013;1:CD004816]. In 2013, the American College of Cardiology and the American Heart Association (ACC/AHA) made recommendations for...
A recent study showed statin...
04/22/2014
First Report Managed Care
06/19/2014
There are an estimated 15 million Medicare beneficiaries using retiree health benefit plans as supplemental coverage. An additional >2 million pre-retirees are also using retiree health benefit plans as a primary source of coverage, making...
There are an estimated 15 million Medicare beneficiaries using retiree health benefit plans as supplemental coverage. An additional >2 million pre-retirees are also using retiree health benefit plans as a primary source of coverage, making...
There are an estimated 15...
06/19/2014
First Report Managed Care
Conference Insider
06/18/2015
An increasing number of aging adults and disabled individuals are enrolling in Medicaid due to the recent decision by many states to expand Medicaid coverage.
An increasing number of aging adults and disabled individuals are enrolling in Medicaid due to the recent decision by many states to expand Medicaid coverage.
An increasing number of...
06/18/2015
First Report Managed Care
12/16/2015
Specialty Pharma: The Good, the Bad, and the Challenging The rising cost of specialty pharmaceuticals is a critical issue among managed care professionals.  
Specialty Pharma: The Good, the Bad, and the Challenging The rising cost of specialty pharmaceuticals is a critical issue among managed care professionals.  
Specialty Pharma: The Good, the...
12/16/2015
First Report Managed Care
News Connection
11/11/2015
A recent study published in Health Affairs found that chronic illness diagnoses are more likely to occur among insured individuals, suggesting that with more individuals covered under the Affordable Care Act (ACA), the number of chronic...
A recent study published in Health Affairs found that chronic illness diagnoses are more likely to occur among insured individuals, suggesting that with more individuals covered under the Affordable Care Act (ACA), the number of chronic...
A recent study published...
11/11/2015
First Report Managed Care
05/21/2014
Tampa—Biologics are regularly used to treat different forms of inflammatory bowel disease (IBD). The most common types of IBD are Crohn’s disease and ulcerative colitis. However, biologic therapies used for IBD cost an estimated $15,000 to...
Tampa—Biologics are regularly used to treat different forms of inflammatory bowel disease (IBD). The most common types of IBD are Crohn’s disease and ulcerative colitis. However, biologic therapies used for IBD cost an estimated $15,000 to...
Tampa—Biologics are regularly...
05/21/2014
First Report Managed Care
Conference Insider
06/18/2015
In 2013, state and local Medicaid spending increased 5.9% and federal Medicaid spending increased 6.2%, with a total increase of 6.1% in Medicaid expenditures.
In 2013, state and local Medicaid spending increased 5.9% and federal Medicaid spending increased 6.2%, with a total increase of 6.1% in Medicaid expenditures.
In 2013, state and local...
06/18/2015
First Report Managed Care
News
07/30/2015
The estimated overall survival rate of patients diagnosed with Stage I Hodgkin lymphoma is 90%, while Stage IV has a 65% survival rate.
The estimated overall survival rate of patients diagnosed with Stage I Hodgkin lymphoma is 90%, while Stage IV has a 65% survival rate.
The estimated overall survival...
07/30/2015
First Report Managed Care